Virbac Balance Sheet Health
Financial Health criteria checks 6/6
Virbac has a total shareholder equity of €994.2M and total debt of €370.0M, which brings its debt-to-equity ratio to 37.2%. Its total assets and total liabilities are €1.8B and €802.0M respectively. Virbac's EBIT is €227.3M making its interest coverage ratio 87.6. It has cash and short-term investments of €158.6M.
Key information
37.2%
Debt to equity ratio
€369.96m
Debt
| Interest coverage ratio | 87.6x |
| Cash | €158.64m |
| Equity | €994.24m |
| Total liabilities | €801.99m |
| Total assets | €1.80b |
Recent financial health updates
Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet
Oct 19
Is Virbac (EPA:VIRP) Using Too Much Debt?
Apr 09Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?
Oct 14These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely
Jun 26We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease
Mar 26Is Virbac (EPA:VIRP) Using Too Much Debt?
Oct 12Recent updates
An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 47% Undervalued
Oct 06Virbac SA Just Beat Revenue Estimates By 6.0%
Sep 18Unpleasant Surprises Could Be In Store For Virbac SA's (EPA:VIRP) Shares
Aug 31Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All
Jun 15Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?
Jun 10Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected
May 21Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results
Mar 22Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?
Jan 18Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up
Dec 27Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet
Oct 19Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?
Sep 26Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching
Sep 05A Look At The Fair Value Of Virbac SA (EPA:VIRP)
Jun 20Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?
May 31Is Virbac (EPA:VIRP) Using Too Much Debt?
Apr 09Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?
Feb 28Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate
Nov 25Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?
Oct 14An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued
Aug 07These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely
Jun 26Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate
May 01We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease
Mar 26Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate
Jan 26Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock
Dec 28A Look At The Fair Value Of Virbac SA (EPA:VIRP)
Oct 27Is Virbac (EPA:VIRP) Using Too Much Debt?
Oct 12Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today
Sep 26Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?
Jul 15Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?
Jun 27Is Virbac (EPA:VIRP) A Risky Investment?
May 27Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)
Mar 24Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?
Mar 12Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching
Feb 22Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?
Feb 03
Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?
Jan 05Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?
Dec 18Financial Position Analysis
Short Term Liabilities: VIRP's short term assets (€877.3M) exceed its short term liabilities (€530.6M).
Long Term Liabilities: VIRP's short term assets (€877.3M) exceed its long term liabilities (€271.4M).
Debt to Equity History and Analysis
Debt Level: VIRP's net debt to equity ratio (21.3%) is considered satisfactory.
Reducing Debt: VIRP's debt to equity ratio has reduced from 94.1% to 37.2% over the past 5 years.
Debt Coverage: VIRP's debt is well covered by operating cash flow (37.5%).
Interest Coverage: VIRP's interest payments on its debt are well covered by EBIT (87.6x coverage).